February 18, 2022

Description

This week on Pharm5:

2022 ASHP Match Rankings now open
Pfizer-BioNTech COVID-19 vaccine on hold for kids <5; bebtelovimab granted EAU
Eversense E3 implanted CGM with 180-day lifespan approved for adults with diabetes
NDA submitted for adagrasib therapy for KRAS G12C mutation non-small cell lung cancer
New York Times highlights current strain on U.S. community pharmacies

References:

Schedule of dates. ASHP Match | Schedule. https://natmatch.com/ashprmp/schedule.html. Published January 6, 2022. Accessed February 17, 2022.
Matching algorithm. ASHP Match | The Matching Algorithm. https://natmatch.com/ashprmp/algorithm.html. Published January 6, 2022. Accessed February 17, 2022.
Hur K. Pfizer director dr. Scott Gottlieb: Shots for kids under 5 delayed due to low Covid cases in trial. CNBC. https://www.cnbc.com/2022/02/14/pfizer-director-dr-scott-gottlieb-shots-for-kids-under-5-delayed-due-to-low-covid-cases-in-trial.html. Published February 14, 2022. Accessed February 17, 2022.
Coronavirus (COVID-19) update: FDA authorizes new monoclonal antibody for treatment of COVID-19 that retains activity against Omicron variant. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-monoclonal-antibody-treatment-covid-19-retains. Accessed February 17, 2022.
Garza M, Mahoney K. 180-day implantable CGM, Eversense E3, approved by the FDA. diaTribe. https://diatribe.org/180-day-implantable-cgm-eversense-e3-approved-fda. Published February 14, 2022. Accessed February 17, 2022.
FDA accepts NDA for Adagrasib for non-small cell lung cancer. Pharmacy Times. https://www.pharmacytimes.com/view/fda-accepts-nda-for-adagrasib-for-non-small-cell-lung-cancer. Published February 16, 2022. Accessed February 17, 2022.
Ngo M. Pharmacists Burned Out by Workload and Demands. The New York Times. February 14, 2022:1.

Connect with us!